OncoMed Pharmaceuticals Inc Operating Expenses
OncoMed Pharmaceuticals Inc reported Operating Expenses of $15.20 million for the 3-month period ending 2018-12-31, per its 10-K filed 2019-03-07.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2019-03-07
- OncoMed Pharmaceuticals Inc operating expenses for the quarter ending 2018-12-31 was $15.20M, a 22.63% increase year-over-year.
- OncoMed Pharmaceuticals Inc operating expenses for the quarter ending 2018-09-30 was $13.73M, a 14.90% decline year-over-year.
- OncoMed Pharmaceuticals Inc operating expenses for the quarter ending 2018-06-30 was $11.76M, a 45.64% decline year-over-year.
- OncoMed Pharmaceuticals Inc operating expenses for the quarter ending 2018-03-31 was $13.78M, a 52.43% decline year-over-year.
- OncoMed Pharmaceuticals Inc operating expenses for fiscal 2018 was $54.47M, a 31.17% decline from fiscal 2017.
- OncoMed Pharmaceuticals Inc operating expenses for fiscal 2017 was $79.13M, a 38.44% decline from fiscal 2016.
- OncoMed Pharmaceuticals Inc operating expenses for fiscal 2016 was $128.54M, a 15.33% increase from fiscal 2015.
- OncoMed Pharmaceuticals Inc operating expenses for fiscal 2015 was $111.46M, a 23.59% increase from fiscal 2014.
| Period end | Operating Expenses 3 month | Operating Expenses 3 month as first filed | Operating Expenses 6 month | Operating Expenses 9 month | Operating Expenses 12 month |
|---|---|---|---|---|---|
| 2018-12-31 | $15.20M 10-K · filed 2019-03-07 | $28.93M derived: sum of 2 quarters · filed 2019-03-07 | $40.69M derived: sum of 3 quarters · filed 2019-03-07 | $54.47M 10-K · filed 2019-03-07 | |
| 2018-09-30 | $13.73M 10-K · filed 2019-03-07 | $25.48M derived: sum of 2 quarters · filed 2019-03-07 | $39.27M 10-Q · filed 2018-11-01 | $51.66M derived: sum of 4 quarters · filed 2019-03-07 | |
| 2018-06-30 | $11.76M 10-K · filed 2019-03-07 | $25.54M 10-Q · filed 2018-08-02 | $37.93M derived: sum of 3 quarters · filed 2019-03-07 | $54.06M derived: sum of 4 quarters · filed 2019-03-07 | |
| 2018-03-31 | $13.78M 10-K · filed 2019-03-07 | $26.18M derived: sum of 2 quarters · filed 2019-03-07 | $42.31M derived: sum of 3 quarters · filed 2019-03-07 | $63.94M derived: sum of 4 quarters · filed 2019-03-07 | |
| 2017-12-31 | $12.39M 10-K · filed 2019-03-07 | $28.53M derived: sum of 2 quarters · filed 2019-03-07 | $50.16M derived: sum of 3 quarters · filed 2019-03-07 | $79.13M 10-K · filed 2019-03-07 | |
| 2017-09-30 | $16.13M 10-K · filed 2019-03-07 | $37.76M derived: sum of 2 quarters · filed 2019-03-07 | $66.73M 10-Q · filed 2018-11-01 | $95.34M derived: sum of 4 quarters · filed 2019-03-07 | |
| 2017-06-30 | $21.63M 10-K · filed 2019-03-07 | $50.60M 10-Q · filed 2018-08-02 | $79.21M derived: sum of 3 quarters · filed 2019-03-07 | $111.06M derived: sum of 4 quarters · filed 2019-03-07 | |
| 2017-03-31 | $28.97M 10-K · filed 2019-03-07 | $57.58M derived: sum of 2 quarters · filed 2019-03-07 | $89.43M derived: sum of 3 quarters · filed 2019-03-07 | $123.91M derived: sum of 4 quarters · filed 2019-03-07 | |
| 2016-12-31 | $28.61M 10-K · filed 2018-03-09 | $60.46M derived: sum of 2 quarters · filed 2018-03-09 | $94.94M derived: sum of 3 quarters · filed 2018-03-09 | $128.54M 10-K · filed 2019-03-07 | |
| 2016-09-30 | $31.85M 10-K · filed 2018-03-09 | $66.33M derived: sum of 2 quarters · filed 2018-03-09 | $99.93M 10-Q · filed 2017-11-02 | $131.59M derived: sum of 4 quarters · filed 2018-03-09 | |
| 2016-06-30 | $34.48M 10-K · filed 2018-03-09 | $68.08M 10-Q · filed 2017-08-02 | $99.74M derived: sum of 3 quarters · filed 2018-03-09 | $128.99M derived: sum of 4 quarters · filed 2018-03-09 | |
| 2016-03-31 | $33.60M 10-K · filed 2018-03-09 | $65.26M derived: sum of 2 quarters · filed 2018-03-09 | $94.50M derived: sum of 3 quarters · filed 2018-03-09 | $120.83M derived: sum of 4 quarters · filed 2018-03-09 | |
| 2015-12-31 | $31.66M 10-K · filed 2017-03-09 | $60.91M derived: sum of 2 quarters · filed 2017-03-09 | $87.23M derived: sum of 3 quarters · filed 2017-03-09 | $111.46M 10-K · filed 2018-03-09 | |
| 2015-09-30 | $29.25M 10-K · filed 2017-03-09 | $55.57M derived: sum of 2 quarters · filed 2017-03-09 | $79.80M 10-Q · filed 2016-11-01 | $103.94M derived: sum of 4 quarters · filed 2017-03-09 | |
| 2015-06-30 | $26.32M 10-K · filed 2017-03-09 | $50.55M 10-Q · filed 2016-08-09 | $74.69M derived: sum of 3 quarters · filed 2017-03-09 | $99.20M derived: sum of 4 quarters · filed 2017-03-09 | |
| 2015-03-31 | $24.23M 10-K · filed 2017-03-09 | $48.37M derived: sum of 2 quarters · filed 2017-03-09 | $72.88M derived: sum of 3 quarters · filed 2017-03-09 | $94.49M derived: sum of 4 quarters · filed 2017-03-09 | |
| 2014-12-31 | $24.14M 10-K · filed 2016-03-10 | -$24.14M 10-K · filed 2015-03-12 | $48.65M derived: sum of 2 quarters · filed 2016-03-10 | $70.26M derived: sum of 3 quarters · filed 2016-03-10 | $90.18M 10-K · filed 2017-03-09 |
| 2014-09-30 | $24.52M 10-K · filed 2016-03-10 | $46.12M derived: sum of 2 quarters · filed 2016-03-10 | $66.04M 10-Q · filed 2015-11-05 | $87.43M derived: sum of 4 quarters · filed 2016-03-10 | |
| 2014-06-30 | $21.61M 10-K · filed 2016-03-10 | $41.53M 10-Q · filed 2015-08-10 | $62.92M derived: sum of 3 quarters · filed 2016-03-10 | $79.22M derived: sum of 4 quarters · filed 2016-03-10 | |
| 2014-03-31 | $19.92M 10-K · filed 2016-03-10 | $41.31M derived: sum of 2 quarters · filed 2016-03-10 | $57.61M derived: sum of 3 quarters · filed 2016-03-10 | $70.04M derived: sum of 4 quarters · filed 2016-03-10 | |
| 2013-12-31 | $21.39M 10-K · filed 2015-03-12 | $37.69M derived: sum of 2 quarters · filed 2015-03-12 | $50.12M derived: sum of 3 quarters · filed 2015-03-12 | $61.68M 10-K · filed 2016-03-10 | |
| 2013-09-30 | $16.30M 10-K · filed 2015-03-12 | $28.73M derived: sum of 2 quarters · filed 2015-03-12 | $40.29M 10-Q · filed 2014-11-04 | $51.55M derived: sum of 4 quarters · filed 2015-03-12 | |
| 2013-06-30 | $12.43M 10-K · filed 2015-03-12 | $23.99M 10-Q · filed 2014-08-07 | $35.25M derived: sum of 3 quarters · filed 2015-03-12 | $46.66M derived: sum of 4 quarters · filed 2015-03-12 | |
| 2013-03-31 | $11.56M 10-K · filed 2015-03-12 | $22.83M derived: sum of 2 quarters · filed 2015-03-12 | $34.24M derived: sum of 3 quarters · filed 2015-03-12 | $45.52M derived: sum of 4 quarters · filed 2015-03-12 | |
| 2012-12-31 | $11.27M 10-K · filed 2014-03-18 | $22.68M derived: sum of 2 quarters · filed 2014-03-18 | $33.96M derived: sum of 3 quarters · filed 2014-03-18 | $47.05M 10-K · filed 2015-03-12 | |
| 2012-09-30 | $11.41M 10-K · filed 2014-03-18 | $22.70M derived: sum of 2 quarters · filed 2014-03-18 | $35.78M 10-Q · filed 2013-11-13 | ||
| 2012-06-30 | $11.29M 10-K · filed 2014-03-18 | $24.37M 10-Q · filed 2013-09-03 | |||
| 2012-03-31 | $13.09M 10-K · filed 2014-03-18 | ||||
| 2011-12-31 | $46.65M 10-K · filed 2014-03-18 |